{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:57:46Z","timestamp":1791215866647,"version":"4.1.0"},"reference-count":81,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["Transpl Int"],"abstract":"<jats:p>While allograft rejection (AR) continues to threaten the success of cardiothoracic transplantation, lack of accurate and repeatable surveillance tools to diagnose AR is a major unmet need in the clinical management of cardiothoracic transplant recipients. Endomyocardial biopsy (EMB) and transbronchial biopsy (TBBx) have been the cornerstone of rejection monitoring since the field\u2019s incipience, but both suffer from significant limitations, including poor concordance of biopsy interpretation among pathologists. In recent years, novel molecular tools for AR monitoring have emerged and their performance characteristics have been evaluated in multiple studies. An international working group convened by ESOT has reviewed the existing literature and provides a series of recommendations to guide the use of these biomarkers in clinical practice. While acknowledging some caveats, the group recognized that Gene-expression profiling and donor-derived cell-free DNA (dd-cfDNA) may be used to rule out rejection in heart transplant recipients, but they are not recommended for cardiac allograft vasculopathy screening. Other traditional biomarkers (NT-proBNP, BNP or troponin) do not have sufficient evidence to support their use to diagnose AR. Regarding lung transplant, dd-cfDNA could be used to rule out clinical rejection and infection, but its use to monitor treatment response is not recommended.<\/jats:p>","DOI":"10.3389\/ti.2024.12445","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T13:43:31Z","timestamp":1718113411000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["European Society for Organ Transplantation (ESOT) Consensus Statement on the Use of Non-invasive Biomarkers for Cardiothoracic Transplant Rejection Surveillance"],"prefix":"10.3389","volume":"37","author":[{"given":"Andriana","family":"Nikolova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Agbor-Enoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Crespo-Leiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ensminger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Jimenez-Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Minervini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Perch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Segovia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Khush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Potena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1097\/TP.0b013e31826e19e2","article-title":"Concordance Among Pathologists in the Second Cardiac Allograft Rejection Gene Expression Observational Study (CARGO II)","volume":"94","author":"Crespo-Leiro","year":"2012","journal-title":"Transplantation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.healun.2017.07.019","article-title":"The Registry of the International Society for Heart and Lung Transplantation: Thirty-Fourth Adult Heart Transplantation Report\u20142017; Focus Theme: Allograft Ischemic Time","volume":"36","author":"Lund","year":"2017","journal-title":"J Heart Lung Transpl"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1161\/CIRCULATIONAHA.120.049098","article-title":"Cell-Free DNA to Detect Heart Allograft Acute Rejection","volume":"143","author":"Agbor-Enoh","year":"2021","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"10915","DOI":"10.3389\/ti.2022.10915","article-title":"ESOT Consensus Platform for Organ Transplantation: Setting the Stage for a Rigorous, Regularly Updated Development Process","volume":"35","author":"Cillo","year":"2022","journal-title":"Transpl Int"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1056\/NEJMoa0912965","article-title":"Gene-Expression Profiling for Rejection Surveillance after Cardiac Transplantation","volume":"362","author":"Pham","year":"2010","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1161\/CIRCHEARTFAILURE.114.001658","article-title":"Randomized Pilot Trial of Gene Expression Profiling versus Heart Biopsy in the First Year after Heart Transplant: Early Invasive Monitoring Attenuation through Gene Expression Trial","volume":"8","author":"Kobashigawa","year":"2015","journal-title":"Circ Heart Fail"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1093\/eurheartj\/ehv682","article-title":"Clinical Usefulness of Gene-Expression Profile to Rule Out Acute Rejection after Heart Transplantation: CARGO II","volume":"37","author":"Crespo-Leiro","year":"2016","journal-title":"Eur Heart J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.healun.2018.09.004","article-title":"Risk Evaluation Using Gene Expression Screening to Monitor for Acute Cellular Rejection in Heart Transplant Recipients","volume":"38","author":"Moayedi","year":"2019","journal-title":"J Heart Lung Transpl"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.015","article-title":"The International Society for Heart and Lung Transplantation (ISHLT) Guidelines for the Care of Heart Transplant Recipients","volume":"42","author":"Velleca","year":"2023","journal-title":"J Heart Lung Transpl"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1111\/ajt.15339","article-title":"Noninvasive Detection of Graft Injury after Heart Transplant Using Donor-Derived Cell-Free DNA: A Prospective Multicenter Study","volume":"19","author":"Khush","year":"2019","journal-title":"Am J Transpl"},{"key":"B11","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.healun.2022.04.002","article-title":"A Novel Donor-Derived Cell-Free DNA Assay for the Detection of Acute Rejection in Heart Transplantation","volume":"41","author":"Kim","year":"2022","journal-title":"J Heart Lung Transpl"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e14206","DOI":"10.1111\/ctr.14206","article-title":"Donor-Derived Cell-Free DNA Is Associated with Cardiac Allograft Vasculopathy","volume":"35","author":"Holzhauser","year":"2021","journal-title":"Clin Transpl"},{"key":"B13","doi-asserted-by":"publisher","first-page":"856600","DOI":"10.3389\/fcvm.2022.856600","article-title":"Lack of Usefulness of Donor-Derived Cell-Free DNA as a Biomarker for Cardiac Allograft Vasculopathy: A Prospective Study","volume":"9","author":"Jim\u00e9nez-Blanco Bravo","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"10546","DOI":"10.3389\/ti.2022.10546","article-title":"Validation of a Simple, Rapid, and Cost-Effective Method for Acute Rejection Monitoring in Lung Transplant Recipients","volume":"35","author":"Sorbini","year":"2022","journal-title":"Transpl Int"},{"key":"B15","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.healun.2007.05.017","article-title":"Molecular Testing for Long-Term Rejection Surveillance in Heart Transplant Recipients: Design of the Invasive Monitoring Attenuation through Gene Expression (IMAGE) Trial","volume":"26","author":"Pham","year":"2007","journal-title":"J Heart Lung Transpl"},{"key":"B16","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1097\/01.TP.0000443897.29951.cf","article-title":"Utility of Gene Expression Profiling Score Variability to Predict Clinical Events in Heart Transplant Recipients","volume":"97","author":"Deng","year":"2014","journal-title":"Transplantation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12872-015-0106-1","article-title":"Performance of Gene-Expression Profiling Test Score Variability to Predict Future Clinical Events in Heart Transplant Recipients","volume":"15","author":"Crespo-Leiro","year":"2015","journal-title":"BMC Cardiovasc Disord"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e13622","DOI":"10.1111\/petr.13622","article-title":"Early Changes in Cell\u2010free DNA Levels in Newly Transplanted Heart Transplant Patients","volume":"24","author":"Zangwill","year":"2020","journal-title":"Pediatr Transpl"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e14509","DOI":"10.1111\/ctr.14509","article-title":"Increase in Nuclear Cell-Free DNA Is Associated with Major Adverse Events in Adult and Pediatric Heart Transplant Recipients","volume":"36","author":"Zangwill","year":"2022","journal-title":"Clin Transpl"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.athoracsur.2020.08.006","article-title":"Total Cell-Free DNA Predicts Death and Infection Following Pediatric and Adult Heart Transplantation","volume":"112","author":"Scott","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1016\/j.healun.2017.01.172","article-title":"Analysis of Donor-Derived Cell-Free DNA with 3-Year Outcomes in Heart Transplant Recipients","volume":"36","author":"Crespo-Leiro","year":"2017","journal-title":"J Heart Lung Transpl"},{"key":"B22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/MOT.0b013e328364fe23","article-title":"Do Established Biomarkers Such as B-Type Natriuretic Peptide and Troponin Predict Rejection?","volume":"18","author":"Hill","year":"2013","journal-title":"Curr Opin Organ Transpl"},{"key":"B23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/tri.12024","article-title":"High-Sensitive Troponin T Measurements Early after Heart Transplantation Predict Short and Long-Term Survival","volume":"26","author":"Erbel","year":"2013","journal-title":"Transpl Int"},{"key":"B24","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.transproceed.2014.10.049","article-title":"Usefulness of High-Sensitivity Troponin I for the Monitoring of Subclinical Acute Cellular Rejection after Cardiac Transplantation","volume":"47","author":"Ahn","year":"2015","journal-title":"Transpl Proc"},{"key":"B25","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/TP.0000000000000378","article-title":"Repeated Measurements of NT-pro-B-type Natriuretic Peptide, Troponin T or C-Reactive Protein Do Not Predict Future Allograft Rejection in Heart Transplant Recipients","volume":"99","author":"Battes","year":"2015","journal-title":"Transplantation"},{"key":"B26","article-title":"Troponin T and I Are Not Reliable Markers of Cardiac Transplant Rejectionq","author":"Mullen","year":"2002","journal-title":"Thorac Surg"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/00007890-200210270-00013","article-title":"Sustained Elevated Concentrations of Cardiac Troponin T during Acute Allograft Rejection after Heart Transplantation in Children1","volume":"74","author":"Wahlander","year":"2002","journal-title":"Transplantation"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1016\/s0041-1345(02)03194-9","article-title":"Extended Experience and Subgroup Analysis Using Cardiac Troponin T for Rejection Monitoring after Heart Transplantation","volume":"34","author":"Gleissner","year":"2002","journal-title":"Transpl Proc"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1016\/j.transproceed.2003.10.044","article-title":"Utility of Biochemical Markers in the Follow-Up of Heart Transplant Recipients","volume":"35","author":"Balduini","year":"2003","journal-title":"Transpl Proc"},{"key":"B30","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1161\/CIRCHEARTFAILURE.113.000697","article-title":"High-Sensitivity Cardiac Troponin I Assay to Screen for Acute Rejection in Patients with Heart Transplant","volume":"7","author":"Patel","year":"2014","journal-title":"Circ Heart Fail"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.rec.2011.06.017","article-title":"Usefulness of High Sensitivity Troponin T Assay in Detecting Acute Allograft Rejection after Heart Transplantation","volume":"64","author":"Mu\u00f1oz-Esparza","year":"2011","journal-title":"Rev Esp Cardiol Engl"},{"key":"B32","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.ahj.2012.02.003","article-title":"Use of a Highly Sensitive Assay for Cardiac Troponin T and N-Terminal Pro-Brain Natriuretic Peptide to Diagnose Acute Rejection in Pediatric Cardiac Transplant Recipients","volume":"163","author":"Dyer","year":"2012","journal-title":"Am Heart J"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e1261","DOI":"10.1097\/TXD.0000000000001261","article-title":"Donor Cardiac Troponin for Prognosis of Adverse Outcomes in Cardiac Transplantation Recipients: A Systematic Review and Meta-Analysis","volume":"8","author":"Liu","year":"2021","journal-title":"Transpl Direct"},{"key":"B34","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.healun.2017.12.008","article-title":"Utility of Troponin Assays for Exclusion of Acute Cellular Rejection after Heart Transplantation: A Systematic Review","volume":"37","author":"Fitzsimons","year":"2018","journal-title":"J Heart Lung Transpl"},{"key":"B35","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1097\/01.mnm.0000084588.29433.2e","article-title":"Radioimmunometric Assay of B-Type Natriuretic Peptide (BNP) in Heart Transplantation: Correlation between BNP Determinations and Biopsy Grading of Rejection","volume":"24","author":"Herv\u00e1s","year":"2003","journal-title":"Nucl Med Commun"},{"key":"B36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.healun.2003.10.012","article-title":"Brain Natriuretic Peptide Predicts Serious Cardiac Allograft Rejection Independent of Hemodynamic Measurements","volume":"24","author":"Wu","year":"2005","journal-title":"J Heart Lung Transpl"},{"key":"B37","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.healun.2008.03.008","article-title":"B-Type Natriuretic Peptide Is a Sensitive Screening Test for Acute Rejection in Pediatric Heart Transplant Patients","volume":"27","author":"Rossano","year":"2008","journal-title":"J Heart Lung Transpl"},{"key":"B38","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.healun.2009.04.019","article-title":"The Change in B-Type Natriuretic Peptide Levels over Time Predicts Significant Rejection in Cardiac Transplant Recipients","volume":"28","author":"Kittleson","year":"2009","journal-title":"J Heart Lung Transpl"},{"key":"B39","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.healun.2012.02.014","article-title":"Changes in Serial B-Type Natriuretic Peptide Level Independently Predict Cardiac Allograft Rejection","volume":"31","author":"Damodaran","year":"2012","journal-title":"J Heart Lung Transpl"},{"key":"B40","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1432-2277.2004.00010.x","article-title":"Determinants of B-Type Natriuretic Peptide Plasma Levels in the Chronic Phase after Heart Transplantation","volume":"18","author":"Klingenberg","year":"2005","journal-title":"Transpl Int"},{"key":"B41","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.healun.2008.04.008","article-title":"Prognostic Relationship between Two Serial Determinations of B-Type Natriuretic Peptide and Medium\u2013Long-Term Events in Heart Transplantation","volume":"27","author":"Mart\u00ednez-Dolz","year":"2008","journal-title":"J Heart Lung Transpl"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.healun.2004.08.018","article-title":"B-Type Natriuretic Peptide as a Marker of Allograft Rejection after Heart Transplantation","volume":"24","author":"Hammerer-Lercher","year":"2005","journal-title":"J Heart Lung Transpl"},{"key":"B43","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1399-3046.2012.01659.x","article-title":"NTproBNP as a Marker of Rejection in Pediatric Heart Transplant Recipients: NTproBNP in Pediatric Heart Transplant","volume":"16","author":"Knecht","year":"2012","journal-title":"Pediatr Transpl"},{"key":"B44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1751-7133.2009.00055.x","article-title":"Time-Dependent Changes in B-Type Natriuretic Peptide after Heart Transplantation: Correlation with Allograft Rejection and Function","volume":"15","author":"Bader","year":"2009","journal-title":"Congest Heart Fail"},{"key":"B45","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.amjcard.2004.11.054","article-title":"Value of Plasma B-Type Natriuretic Peptide as a Marker for Rejection in Pediatric Heart Transplant Recipients","volume":"95","author":"Lindblade","year":"2005","journal-title":"Am J Cardiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.amjcard.2004.04.060","article-title":"Usefulness of an Elevated B-Type Natriuretic Peptide to Predict Allograft Failure, Cardiac Allograft Vasculopathy, and Survival after Heart Transplantation","volume":"94","author":"Mehra","year":"2004","journal-title":"Am J Cardiol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.amjcard.2004.08.049","article-title":"Usefulness of N-Terminal\u2013Pro-Brain Natriuretic Peptide Levels in Predicting Survival in Heart Transplant Recipients","volume":"94","author":"Ambrosi","year":"2004","journal-title":"Am J Cardiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/s0041-1345(01)02716-6","article-title":"The Value of Brain Natriuretic Peptide for the Diagnosis of Heart Transplant Rejection","volume":"34","author":"Almenar","year":"2002","journal-title":"Transpl Proc"},{"key":"B49","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.healun.2003.08.005","article-title":"Predictive Value of Brain Natriuretic Peptide in the Diagnosis of Heart Transplant Rejection","volume":"23","author":"Arnau-Vives","year":"2004","journal-title":"J Heart Lung Transpl"},{"key":"B50","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.healun.2003.12.006","article-title":"Brain Natriuretic Peptide Levels Do Not Correlate with Acute Cellular Rejection in De Novo Orthotopic Heart Transplant Recipients","volume":"24","author":"O\u2019Neill","year":"2005","journal-title":"J Heart Lung Transpl"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1097\/01.tp.0000263338.39555.21","article-title":"Probrain Natriuretic Peptide and C-Reactive Protein as Markers of Acute Rejection, Allograft Vasculopathy, and Mortality in Heart Transplantation","volume":"83","author":"Arora","year":"2007","journal-title":"Transplantation"},{"key":"B52","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.healun.2021.04.009","article-title":"Donor-Derived Cell-Free DNA Accurately Detects Acute Rejection in Lung Transplant Patients, a Multicenter Cohort Study","volume":"40","author":"Jang","year":"2021","journal-title":"J Heart Lung Transpl"},{"key":"B53","doi-asserted-by":"publisher","first-page":"13336","DOI":"10.1073\/pnas.1517494112","article-title":"Noninvasive Monitoring of Infection and Rejection after Lung Transplantation","volume":"112","author":"De Vlaminck","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e1317","DOI":"10.1097\/TXD.0000000000001317","article-title":"Clinical Validation of a Plasma Donor-Derived Cell-Free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant","volume":"8","author":"Rosenheck","year":"2022","journal-title":"Transpl Direct"},{"key":"B55","doi-asserted-by":"publisher","first-page":"00462","DOI":"10.1183\/23120541.00462-2020","article-title":"Donor-derived, Cell-Free DNA Levels by Next-Generation Targeted Sequencing Are Elevated in Allograft Rejection after Lung Transplantation","volume":"7","author":"Khush","year":"2021","journal-title":"ERJ Open Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1111\/ajt.17039","article-title":"Comparison of Donor-Derived Cell-Free DNA between Single versus Double Lung Transplant Recipients","volume":"22","author":"Keller","year":"2022","journal-title":"Am J Transpl"},{"key":"B57","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.healun.2018.01.1305","article-title":"Late Manifestation of Alloantibody-Associated Injury and Clinical Pulmonary Antibody-Mediated Rejection: Evidence from Cell-Free DNA Analysis","volume":"37","author":"Agbor-Enoh","year":"2018","journal-title":"J Heart Lung Transpl"},{"key":"B58","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.healun.2021.12.009","article-title":"Donor-derived Cell-Free DNA as a Composite Marker of Acute Lung Allograft Dysfunction in Clinical Care","volume":"41","author":"Keller","year":"2022","journal-title":"J Heart Lung Transpl"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e608","DOI":"10.1097\/TXD.0000000000001063","article-title":"Plasma Donor-Derived Cell-Free DNA Levels Are Increased during Acute Cellular Rejection after Lung Transplant: Pilot Data","volume":"6","author":"Sayah","year":"2020","journal-title":"Transpl Direct"},{"key":"B60","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/jalm\/jfab171","article-title":"Biological Variation of Donor-Derived Cell-Free DNA in Stable Lung Transplant Recipients","volume":"7","author":"Keller","year":"2022","journal-title":"J Appl Lab Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ebiom.2018.12.029","article-title":"Donor-Derived Cell-Free DNA Predicts Allograft Failure and Mortality after Lung Transplantation","volume":"40","author":"Agbor-Enoh","year":"2019","journal-title":"EBioMedicine"},{"key":"B62","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.healun.2021.02.008","article-title":"Use of Donor-derived Cell-Free DNA as a Marker of Early Allograft Injury in Primary Graft Dysfunction (PGD) to Predict the Risk of Chronic Lung Allograft Dysfunction (CLAD)","volume":"40","author":"Keller","year":"2021","journal-title":"J Heart Lung Transpl"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1111\/ajt.17125","article-title":"Elevated Cell-Free DNA in Respiratory Viral Infection and Associated Lung Allograft Dysfunction","volume":"22","author":"Bazemore","year":"2022","journal-title":"Am J Transpl"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.healun.2022.06.019","article-title":"Circulating microRNAs in Cellular and Antibody-Mediated Heart Transplant Rejection","volume":"41","author":"Shah","year":"2022","journal-title":"J Heart Lung Transpl"},{"key":"B65","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/cvr\/cvw244","article-title":"Exosomal miR-142-3p Is Increased during Cardiac Allograft Rejection and Augments Vascular Permeability through Down-Regulation of Endothelial RAB11FIP2 Expression","volume":"113","author":"Sukma Dewi","year":"2017","journal-title":"Cardiovasc Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1093\/eurheartj\/ehu346","article-title":"MicroRNAs as Non-Invasive Biomarkers of Heart Transplant Rejection","volume":"35","author":"Duong Van Huyen","year":"2014","journal-title":"Eur Heart J"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.healun.2020.06.011","article-title":"Circulating Extracellular Vesicles as Non-Invasive Biomarker of Rejection in Heart Transplant","volume":"39","author":"Castellani","year":"2020","journal-title":"J Heart Lung Transpl"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.healun.2020.05.018","article-title":"Circulating miR-181a-5p as a New Biomarker for Acute Cellular Rejection in Heart Transplantation","volume":"39","author":"Constanso-Conde","year":"2020","journal-title":"J Heart Lung Transpl"},{"key":"B69","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.healun.2017.07.012","article-title":"Serum Exosomal Protein Profiling for the Non-Invasive Detection of Cardiac Allograft Rejection","volume":"37","author":"Kennel","year":"2018","journal-title":"J Heart Lung Transpl"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/j.jtcvs.2017.12.125","article-title":"Donor Tissue-Specific Exosome Profiling Enables Noninvasive Monitoring of Acute Rejection in Mouse Allogeneic Heart Transplantation","volume":"155","author":"Habertheuer","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1093\/eurheartj\/ehab241","article-title":"An Automated Computational Image Analysis Pipeline for Histological Grading of Cardiac Allograft Rejection","volume":"42","author":"Peyster","year":"2021","journal-title":"Eur Heart J"},{"key":"B72","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jacbts.2020.01.015","article-title":"In Situ Immune Profiling of Heart Transplant Biopsies Improves Diagnostic Accuracy and Rejection Risk Stratification","volume":"5","author":"Peyster","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1161\/circulationaha.121.058459","article-title":"Computational Analysis of Routine Biopsies Improves Diagnosis and Prediction of Cardiac Allograft Vasculopathy","volume":"145","author":"Peyster","year":"2022","journal-title":"Circulation"},{"key":"B74","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/tp.0000000000004323","article-title":"The Molecular Microscope Diagnostic System: Assessment of Rejection and Injury in Heart Transplant Biopsies","volume":"107","author":"Halloran","year":"2023","journal-title":"Transplantation"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.3390\/biom12081135","article-title":"A Review of Biomarkers of Cardiac Allograft Rejection: Toward an Integrated Diagnosis of Rejection","volume":"12","author":"Coutance","year":"2022","journal-title":"Biomolecules"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.healun.2017.05.029","article-title":"Building a Tissue-Based Molecular Diagnostic System in Heart Transplant Rejection: The Heart Molecular Microscope Diagnostic (MMDx) System","volume":"36","author":"Halloran","year":"2017","journal-title":"J Heart Lung Transpl"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1111\/ajt.17087","article-title":"Evolving the Surveillance and Workup of Heart Transplant Rejection: A Real-World Analysis of the Molecular Microscope Diagnostic System","volume":"22","author":"Alam","year":"2022","journal-title":"Am J Transpl"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.jcmg.2019.01.026","article-title":"Multiparametric Cardiac Magnetic Resonance Imaging Can Detect Acute Cardiac Allograft Rejection after Heart Transplantation","volume":"12","author":"Dolan","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/j.jcmg.2018.10.027","article-title":"Native T(1) Mapping in the Diagnosis of Cardiac Allograft Rejection: A Prospective Histologically Validated Study","volume":"12","author":"Imran","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"B80","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12968-014-0052-6","article-title":"Multiparametric Cardiovascular Magnetic Resonance Surveillance of Acute Cardiac Allograft Rejection and Characterisation of Transplantation-Associated Myocardial Injury: A Pilot Study","volume":"16","author":"Miller","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1161\/CIRCULATIONAHA.121.057006","article-title":"Cardiovascular Magnetic Resonance for Rejection Surveillance after Cardiac Transplantation","volume":"145","author":"Anthony","year":"2022","journal-title":"Circulation"}],"container-title":["Transplant International"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2024.12445\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T09:53:55Z","timestamp":1718790835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2024.12445\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":81,"alternative-id":["10.3389\/ti.2024.12445"],"URL":"https:\/\/doi.org\/10.3389\/ti.2024.12445","relation":{},"ISSN":["1432-2277"],"issn-type":[{"value":"1432-2277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,11]]},"article-number":"12445"}}